{"entity":{"type":"insider","cik":"0001618451","url":"/insider/0001618451","json_url":"/insider/0001618451.json","name":"Cormorant Global Healthcare GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":12,"first":"2016-11-07","last":"2018-11-02","span_basis":"filed_date"},"name_variants":[{"name":"Cormorant Global Healthcare GP, LLC","source":"filing","n_filings":12,"first_seen":"2016-11-07","last_seen":"2018-11-02"}],"transactions":[{"id":6245590,"accession":"0001567619-18-005006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-005006","line_url":"/filing/0001567619-18-005006#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Axonics Modulation Technologies, Inc.","issuer_ticker":"AXNX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133333.0,"shares_display":"133,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1999995.0,"total_display":"1,999,995.00","total_whole":"1,999,995","shares_owned_after":1285827.0,"shares_owned_after_display":"1,285,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-31","filed_date":"2018-11-02","scope":"insider"},{"id":6251154,"accession":"0001140361-18-030192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-030192","line_url":"/filing/0001140361-18-030192#line-3","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP","owner_display_name":"Cormorant Global Healthcare GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":1572909.0,"shares_owned_after_display":"1,572,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider"},{"id":6134931,"accession":"0001140361-18-026543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-026543","line_url":"/filing/0001140361-18-026543#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LP; Chen Bihua","owner_display_name":"Cormorant Global Healthcare GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69444.0,"shares_display":"69,444","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":1249992.0,"total_display":"1,249,992.00","total_whole":"1,249,992","shares_owned_after":900443.0,"shares_owned_after_display":"900,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-31","scope":"insider"},{"id":4995885,"accession":"0001140361-17-046489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-046489","line_url":"/filing/0001140361-17-046489#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":504027.0,"shares_display":"504,027","price_per_share":4.883,"price_display":"4.88","price_state":"stated","total_value":2461163.841,"total_display":"2,461,163.84","total_whole":"2,461,164","shares_owned_after":3300000.0,"shares_owned_after_display":"3,300,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-18","scope":"insider"},{"id":4126705,"accession":"0001140361-17-042815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-042815","line_url":"/filing/0001140361-17-042815#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":null,"owner_name":"Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Cormorant Global Healthcare GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1071428.0,"shares_display":"1,071,428","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":14999992.0,"total_display":"14,999,992.00","total_whole":"14,999,992","shares_owned_after":3473925.0,"shares_owned_after_display":"3,473,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-14","scope":"insider"},{"id":2255163,"accession":"0001140361-16-089670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-089670","line_url":"/filing/0001140361-16-089670#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LLC","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21301.0,"shares_display":"21,301","price_per_share":10.9833,"price_display":"10.98","price_state":"stated","total_value":233955.2733,"total_display":"233,955.27","total_whole":"233,955","shares_owned_after":3804027.0,"shares_owned_after_display":"3,804,027","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-13","filed_date":"2016-12-14","scope":"insider"},{"id":2255160,"accession":"0001140361-16-089670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-089670","line_url":"/filing/0001140361-16-089670#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LLC","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.7895,"price_display":"10.79","price_state":"stated","total_value":1078950.0,"total_display":"1,078,950.00","total_whole":"1,078,950","shares_owned_after":3782726.0,"shares_owned_after_display":"3,782,726","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-12","filed_date":"2016-12-14","scope":"insider"},{"id":3367264,"accession":"0001140361-16-089278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-089278","line_url":"/filing/0001140361-16-089278#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Asset Management, LLC; Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Cormorant Asset Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21819.0,"shares_display":"21,819","price_per_share":10.93,"price_display":"10.93","price_state":"stated","total_value":238481.67,"total_display":"238,481.67","total_whole":"238,482","shares_owned_after":3682726.0,"shares_owned_after_display":"3,682,726","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-09","scope":"insider"},{"id":3367262,"accession":"0001140361-16-089278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-089278","line_url":"/filing/0001140361-16-089278#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Asset Management, LLC; Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Cormorant Asset Management, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22598.0,"shares_display":"22,598","price_per_share":10.7402,"price_display":"10.74","price_state":"stated","total_value":242707.0396,"total_display":"242,707.04","total_whole":"242,707","shares_owned_after":3660907.0,"shares_owned_after_display":"3,660,907","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-09","scope":"insider"},{"id":3332208,"accession":"0001140361-16-088915","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-088915","line_url":"/filing/0001140361-16-088915#line-3","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8216.0,"shares_display":"8,216","price_per_share":10.8862,"price_display":"10.89","price_state":"stated","total_value":89441.0192,"total_display":"89,441.02","total_whole":"89,441","shares_owned_after":3638309.0,"shares_owned_after_display":"3,638,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-06","filed_date":"2016-12-06","scope":"insider"},{"id":3332205,"accession":"0001140361-16-088915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-088915","line_url":"/filing/0001140361-16-088915#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29757.0,"shares_display":"29,757","price_per_share":10.7834,"price_display":"10.78","price_state":"stated","total_value":320881.6338,"total_display":"320,881.63","total_whole":"320,882","shares_owned_after":3630093.0,"shares_owned_after_display":"3,630,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-06","scope":"insider"},{"id":3332198,"accession":"0001140361-16-088915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-088915","line_url":"/filing/0001140361-16-088915#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Global Healthcare GP, LLC; Cormorant Asset Management, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":10.476,"price_display":"10.48","price_state":"stated","total_value":523800.0,"total_display":"523,800.00","total_whole":"523,800","shares_owned_after":3600336.0,"shares_owned_after_display":"3,600,336","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-02","filed_date":"2016-12-06","scope":"insider"},{"id":2155574,"accession":"0001140361-16-088417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-088417","line_url":"/filing/0001140361-16-088417#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41984.0,"shares_display":"41,984","price_per_share":10.1132,"price_display":"10.11","price_state":"stated","total_value":424592.5888,"total_display":"424,592.59","total_whole":"424,593","shares_owned_after":3550336.0,"shares_owned_after_display":"3,550,336","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-01","scope":"insider"},{"id":2155570,"accession":"0001140361-16-088417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-088417","line_url":"/filing/0001140361-16-088417#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":128407.0,"shares_display":"128,407","price_per_share":10.2761,"price_display":"10.28","price_state":"stated","total_value":1319523.1727,"total_display":"1,319,523.17","total_whole":"1,319,523","shares_owned_after":3508352.0,"shares_owned_after_display":"3,508,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-12-01","scope":"insider"},{"id":2287390,"accession":"0001140361-16-087797","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-087797","line_url":"/filing/0001140361-16-087797","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180500.0,"shares_display":"180,500","price_per_share":11.37122216066482,"price_display":"11.37","price_state":"stated","total_value":2052505.6,"total_display":"2,052,505.60","total_whole":"2,052,506","shares_owned_after":3379745.0,"shares_owned_after_display":"3,379,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-11-23","scope":"insider","n_lines":2},{"id":2287373,"accession":"0001140361-16-087797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-087797","line_url":"/filing/0001140361-16-087797#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69500.0,"shares_display":"69,500","price_per_share":11.0765,"price_display":"11.08","price_state":"stated","total_value":769816.75,"total_display":"769,816.75","total_whole":"769,817","shares_owned_after":3199445.0,"shares_owned_after_display":"3,199,445","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-23","scope":"insider"},{"id":2287369,"accession":"0001140361-16-087797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-087797","line_url":"/filing/0001140361-16-087797#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":111863.0,"shares_display":"111,863","price_per_share":11.6448,"price_display":"11.64","price_state":"stated","total_value":1302622.2624,"total_display":"1,302,622.26","total_whole":"1,302,622","shares_owned_after":3129945.0,"shares_owned_after_display":"3,129,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-23","scope":"insider"},{"id":3047794,"accession":"0001140361-16-086577","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-086577","line_url":"/filing/0001140361-16-086577#line-4","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":11.4754,"price_display":"11.48","price_state":"stated","total_value":109016.3,"total_display":"109,016.30","total_whole":"109,016","shares_owned_after":3018082.0,"shares_owned_after_display":"3,018,082","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-14","scope":"insider"},{"id":3047788,"accession":"0001140361-16-086577","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-086577","line_url":"/filing/0001140361-16-086577#line-3","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21200.0,"shares_display":"21,200","price_per_share":11.4611,"price_display":"11.46","price_state":"stated","total_value":242975.32,"total_display":"242,975.32","total_whole":"242,975","shares_owned_after":3008582.0,"shares_owned_after_display":"3,008,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-14","scope":"insider"},{"id":3047786,"accession":"0001140361-16-086577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-086577","line_url":"/filing/0001140361-16-086577#line-2","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":216700.0,"shares_display":"216,700","price_per_share":11.0687,"price_display":"11.07","price_state":"stated","total_value":2398587.29,"total_display":"2,398,587.29","total_whole":"2,398,587","shares_owned_after":2987382.0,"shares_owned_after_display":"2,987,382","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-10","filed_date":"2016-11-14","scope":"insider"},{"id":3047781,"accession":"0001140361-16-086577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-086577","line_url":"/filing/0001140361-16-086577#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Global Healthcare GP, LLC; Chen Bihua; Cormorant Asset Management, LLC","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12100.0,"shares_display":"12,100","price_per_share":9.6794,"price_display":"9.68","price_state":"stated","total_value":117120.74,"total_display":"117,120.74","total_whole":"117,121","shares_owned_after":2770682.0,"shares_owned_after_display":"2,770,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":2108547,"accession":"0001140361-16-085212","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-085212","line_url":"/filing/0001140361-16-085212#line-4","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":231700.0,"shares_display":"231,700","price_per_share":8.6863,"price_display":"8.69","price_state":"stated","total_value":2012615.71,"total_display":"2,012,615.71","total_whole":"2,012,616","shares_owned_after":2758582.0,"shares_owned_after_display":"2,758,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-07","scope":"insider"},{"id":2108545,"accession":"0001140361-16-085212","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-085212","line_url":"/filing/0001140361-16-085212","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76000.0,"shares_display":"76,000","price_per_share":8.064490892105264,"price_display":"8.06","price_state":"stated","total_value":612901.3078,"total_display":"612,901.31","total_whole":"612,901","shares_owned_after":2526882.0,"shares_owned_after_display":"2,526,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-04","filed_date":"2016-11-07","scope":"insider","n_lines":2},{"id":2108538,"accession":"0001140361-16-085212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-085212","line_url":"/filing/0001140361-16-085212#line-1","is_derivative":false,"issuer_cik":"0001445283","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001445283","owner_cik":null,"owner_name":"Cormorant Global Healthcare Master Fund, LP; Cormorant Asset Management, LLC; Cormorant Global Healthcare GP, LLC; Chen Bihua","owner_display_name":"Cormorant Global Healthcare Master Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20277.0,"shares_display":"20,277","price_per_share":7.2379,"price_display":"7.24","price_state":"stated","total_value":146762.8983,"total_display":"146,762.90","total_whole":"146,763","shares_owned_after":2450882.0,"shares_owned_after_display":"2,450,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-03","filed_date":"2016-11-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001603756","name":"Axonics Modulation Technologies, Inc.","url":"/issuer/0001603756","role":"Ten percent owner","n_filings":1,"first_seen":"2018-11-02","last_seen":"2018-11-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Ten percent owner","n_filings":1,"first_seen":"2018-06-27","last_seen":"2018-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals, Ltd.","url":"/issuer/0001730430","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-31","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Ten percent owner","n_filings":8,"first_seen":"2016-11-07","last_seen":"2017-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-14","last_seen":"2017-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618451","retrieved_at":"2026-08-25T23:51:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}